Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-005736-17Phase 3Terminated
Phase 3 trial of colistin and tobramycin in surgical site infection (SSI) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Composite of deep surgical site infection and/or mortality. Started Jun 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-005736-17.